SCHEMBL7708012

SCHEMBL7708012

CC1=C(N)Nc2cc(C(c3ccncc3)N(C)C(=O)OC(C)(C)C)ccc2O1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4D Q6B0I6 1/20 0.35
AAK1 Q2M2I8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711069 0.90 CYP3A4 (0.31)
SCHEMBL7710851 0.87 AAK1 (0.31) AAK1
SCHEMBL7711553 0.85 CYP2C19 (0.32)
SCHEMBL7708337 0.85 ALDH1A1 (0.30)
SCHEMBL7705087 0.82 EDNRA (0.31)
SCHEMBL7710769 0.79 KDM4D (0.35) KDM4DAAK1
SCHEMBL6999571 0.75
SCHEMBL7704892 0.75
SCHEMBL7710993 0.73 KDM4E (0.30)
SCHEMBL7710216 0.72 HSD17B10 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed